NZ700064A - Biorelevant compositions - Google Patents
Biorelevant compositionsInfo
- Publication number
- NZ700064A NZ700064A NZ700064A NZ70006413A NZ700064A NZ 700064 A NZ700064 A NZ 700064A NZ 700064 A NZ700064 A NZ 700064A NZ 70006413 A NZ70006413 A NZ 70006413A NZ 700064 A NZ700064 A NZ 700064A
- Authority
- NZ
- New Zealand
- Prior art keywords
- biorelevant
- fasted state
- fatty acid
- sodium
- homogeneous
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 abstract 1
- 239000003833 bile salt Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 abstract 1
- 229940045946 sodium taurodeoxycholate Drugs 0.000 abstract 1
- YXHRQQJFKOHLAP-FVCKGWAHSA-M sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 YXHRQQJFKOHLAP-FVCKGWAHSA-M 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
- G09B23/303—Anatomical models specially adapted to simulate circulation of bodily fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Computational Mathematics (AREA)
- Educational Administration (AREA)
- Mathematical Analysis (AREA)
- Business, Economics & Management (AREA)
- Algebra (AREA)
- Pure & Applied Mathematics (AREA)
- Mathematical Optimization (AREA)
- Mathematical Physics (AREA)
- Educational Technology (AREA)
- Theoretical Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12162548.7A EP2645099A1 (en) | 2012-03-30 | 2012-03-30 | Biorelevant compositions |
| PCT/EP2013/056945 WO2013144374A1 (en) | 2012-03-30 | 2013-04-02 | Biorelevant compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ700064A true NZ700064A (en) | 2016-08-26 |
Family
ID=48143258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ700064A NZ700064A (en) | 2012-03-30 | 2013-04-02 | Biorelevant compositions |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150064794A1 (https=) |
| EP (2) | EP2645099A1 (https=) |
| JP (1) | JP6348480B2 (https=) |
| KR (1) | KR20140144255A (https=) |
| CN (1) | CN104582689A (https=) |
| BR (1) | BR112014024256A8 (https=) |
| CA (1) | CA2867638A1 (https=) |
| IN (1) | IN2014DN07927A (https=) |
| MX (1) | MX357927B (https=) |
| NZ (1) | NZ700064A (https=) |
| WO (1) | WO2013144374A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102034606B1 (ko) * | 2011-08-23 | 2019-10-22 | 알레간 세일즈, 엘엘씨 | 데옥시콜린산 및 그의 염들의 제형물들 |
| WO2019199238A1 (en) * | 2018-04-09 | 2019-10-17 | Vet Products Research And Innovation Center Company Limited | Inorganic mineral entrapped in nanoparticle production method thereof |
| GB201809627D0 (en) * | 2018-06-12 | 2018-07-25 | Biorelevant Com Ltd | Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling |
| GB201904757D0 (en) * | 2019-04-04 | 2019-05-22 | Biorelevant Com Ltd | Biorelevant composition |
| CN114080539A (zh) * | 2019-06-28 | 2022-02-22 | 詹森药业有限公司 | 生物相关溶出介质 |
| WO2021165386A1 (de) | 2020-02-19 | 2021-08-26 | Bayer Aktiengesellschaft | Vorhersage von formulierungseigenschaften |
| GB202112975D0 (en) | 2021-09-10 | 2021-10-27 | Biorelevant Com Ltd | Biorelevant dissolution compositions with reproducible spectral profiles |
| GB202405714D0 (en) * | 2024-04-23 | 2024-06-05 | Biorelevant Com Ltd | Biorelevant compositions and media for in vitro testing |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4874795A (en) * | 1985-04-02 | 1989-10-17 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
| GB8909022D0 (en) * | 1989-04-20 | 1989-06-07 | Cortecs Ltd | Pharmaceutical compositions |
| US6040188A (en) * | 1997-11-18 | 2000-03-21 | The Regents Of The University Of California | In vitro gastrointestinal mimetic protocol for measuring bioavailable contaminants |
| IT1296914B1 (it) * | 1997-12-01 | 1999-08-03 | Maria Rosa Gasco | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
| WO2003042392A1 (en) * | 2001-11-15 | 2003-05-22 | Phares Pharmaceutical Research N.V. | Standardised phospholipid mixtures |
| CA2560900A1 (en) * | 2004-03-26 | 2005-10-06 | Cell Therapeutics Europe S.R.L. | Nanoparticle formulations of platinum compounds |
| GB0522942D0 (en) * | 2005-11-10 | 2005-12-21 | Leigh Steven | Dissolution composition |
| WO2007085970A2 (en) * | 2006-01-27 | 2007-08-02 | Danisco A/S | Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders |
| WO2008040799A2 (en) | 2006-10-06 | 2008-04-10 | Boehringer Ingelheim International Gmbh | Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release |
-
2012
- 2012-03-30 EP EP12162548.7A patent/EP2645099A1/en not_active Ceased
-
2013
- 2013-04-02 CN CN201380018498.8A patent/CN104582689A/zh active Pending
- 2013-04-02 BR BR112014024256A patent/BR112014024256A8/pt not_active Application Discontinuation
- 2013-04-02 CA CA2867638A patent/CA2867638A1/en not_active Abandoned
- 2013-04-02 IN IN7927DEN2014 patent/IN2014DN07927A/en unknown
- 2013-04-02 EP EP13717734.1A patent/EP2830592A1/en not_active Withdrawn
- 2013-04-02 NZ NZ700064A patent/NZ700064A/en not_active IP Right Cessation
- 2013-04-02 JP JP2015502383A patent/JP6348480B2/ja not_active Expired - Fee Related
- 2013-04-02 US US14/389,701 patent/US20150064794A1/en not_active Abandoned
- 2013-04-02 MX MX2014011789A patent/MX357927B/es active IP Right Grant
- 2013-04-02 WO PCT/EP2013/056945 patent/WO2013144374A1/en not_active Ceased
- 2013-04-02 KR KR1020147030491A patent/KR20140144255A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014024256A2 (https=) | 2017-06-20 |
| IN2014DN07927A (https=) | 2015-05-01 |
| BR112014024256A8 (pt) | 2018-02-06 |
| EP2645099A1 (en) | 2013-10-02 |
| CA2867638A1 (en) | 2013-10-03 |
| US20150064794A1 (en) | 2015-03-05 |
| MX2014011789A (es) | 2015-06-03 |
| JP2015524913A (ja) | 2015-08-27 |
| MX357927B (es) | 2018-07-27 |
| WO2013144374A1 (en) | 2013-10-03 |
| CN104582689A (zh) | 2015-04-29 |
| JP6348480B2 (ja) | 2018-06-27 |
| EP2830592A1 (en) | 2015-02-04 |
| KR20140144255A (ko) | 2014-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ700064A (en) | Biorelevant compositions | |
| GB201212223D0 (en) | Electrical connectors | |
| MY159212A (en) | Nutritional compositions with coated lipid globules | |
| RU2010129985A (ru) | Композиции питательного порошка и детской питательной смеси (варианты) | |
| MA35195B1 (fr) | Compositions lipidiques algales, leurs procédés de préparation et leurs utilisations | |
| MX358067B (es) | Composiciones solubles en agua que incorporan enzimas, y método para fabricar las mismas. | |
| EP4238420A3 (en) | Whey protein compositions, methods and uses | |
| MX2010006197A (es) | Composicion nutricional enterica liquida con alto contenido de energia. | |
| WO2014020447A3 (en) | Protein adhesives | |
| WO2011114239A3 (en) | Fat-binding compositions | |
| TW200833318A (en) | An extract | |
| IN2014DN03449A (https=) | ||
| MX2009003600A (es) | Composiciones que tienen un compartimiento indicador. | |
| DK1996028T3 (da) | Faste enzymformuleringer og fremgangsmåde til deres fremstilling | |
| AR077860A1 (es) | Productos horneados de humedad intermedia y larga vida | |
| BR112013032595A2 (pt) | produtos para o consumidor com partículas revestidas que compreendem lipase | |
| BR112013027086A2 (pt) | composto, composição aquosa, composição de emulsão, composição bifásica, método de deslocamento de um material de hidrocarboneto em contato com um material sólido, método de conversão de um ácido de petróleo não refinado em um tensoativo e método de preparação de um composto | |
| WO2013049519A3 (en) | Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols | |
| WO2009143133A3 (en) | Compositions and methods to protect cells by blocking entry of pathogen proteins | |
| WO2014088830A3 (en) | Screening of nucleic acid agents via particle display | |
| ZA200805731B (en) | Compositions and method for promoting fat loss | |
| NO20082078L (no) | Dissosiasjonssammensetning for å undersøke medikamentløselighet | |
| MY199653A (en) | Encapsulated nutritional and pharmaceutical compositions | |
| EA200801813A1 (ru) | Содержащие жирные кислоты побочные продукты и способы их применения | |
| MX355131B (es) | Emulsion de aceite en agua estable al calor. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: BIORELEVANT.COM LTD, GB Effective date: 20161020 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 APR 2018 BY JAMES + WELLS Effective date: 20170331 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 APR 2019 BY JAMES + WELLS Effective date: 20180321 |
|
| LAPS | Patent lapsed |